[Efficacy and safety in treatment of ocular neovascularization by Bevacizumab versus Ranibizumab: a meta-analysis]. [electronic resource]
Producer: 20101110Description: 263-7 p. digitalISSN:- 0412-4081
- Angiogenesis Inhibitors -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Choroidal Neovascularization -- drug therapy
- Controlled Clinical Trials as Topic
- Eye Diseases -- drug therapy
- Humans
- Neovascularization, Pathologic -- drug therapy
- Ranibizumab
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.